Speaker's Highlight

• Don Sin University of British Columbia, St. Paul Hospital (Canada)
  Kenneth R. Chapman Toronto General Hospital Research Institute (Canada)
• Parameswaran Nair McMaster University (Canada)
  Carolyn Calfee UCSF (U.S.A.)
• Gregory P. Downey University of Colorado School of Medicine (U.S.A.)
  David A. Schwartz University of Colorado School of Medicine (U.S.A.)
• Neil Schluger Tuberculosis Control Branch, California Department of Public Health (U.S.A.)
  Nick Kim Critical Care & Sleep Medicine, University of California San Diego (U.S.A.)
• Nicola Hananiah Baylor College of Medicine (U.S.A.)
  Jae-Joon Yim Seoul National University College of Medicine (Republic of Korea)
• Koichiro Asano Tokai University School of Medicine (Japan)
  Diahn-Warng Perng Taipei Veterans General Hospital (Taiwan)
• Konstantinos Kostikas University of Ioannina (Greece)
  Karin Klooster University Medical Center Groningen (Kingdom of the Netherlands)

• How Air Pollution Shapes Respiratory Health Outcomes

  Air pollution is a major, preventable driver of respiratory illness. The particles and gases released by traffic, industry, household fuel burning, construction, agriculture, and wildfires can reach deep into the lungs, aggravating existing disease and contributing to new health problems.

  The impact is influenced by pollutant concentration, exposure duration, weather, geography, and individual vulnerability. A brief exposure to heavy pollution may trigger wheezing or chest tightness, while repeated exposure over months or years can alter lung development, accelerate lung-function decline, and raise the risk of chronic disease.

  Respiratory specialists increasingly view air quality as a clinical factor alongside smoking history, infection, genetics, and workplace exposure. Discussions at international respiratory medicine meetings, including those connected with APSR and KATRD, help translate environmental research into practical prevention and treatment.

  Pollutants That Reach The Airways

  Fine particulate matter, commonly called PM2.5, is among the most concerning pollutants because its tiny particles can pass beyond the upper airway and settle in the bronchioles and alveoli. Diesel exhaust, combustion smoke, industrial emissions, and wildfire haze are frequent sources. Larger particles, or PM10, can irritate the nose and throat while also worsening bronchial inflammation.

  Ozone and nitrogen dioxide are harmful gases associated with traffic, sunlight-driven chemical reactions, and fuel combustion. Ozone can inflame airway tissue and reduce lung performance, especially during physical activity. Nitrogen dioxide may increase airway sensitivity and has been linked with asthma symptoms, respiratory infections, and impaired lung development in children. Indoor pollutants, including cooking smoke, tobacco smoke, mold, and volatile chemicals, add another important exposure pathway.

  From Exposure To Respiratory Injury

  When polluted air is inhaled, the respiratory system responds with oxidative stress and inflammation. The airway lining may produce excess mucus, the bronchial muscles can tighten, and the cilia responsible for clearing particles may work less effectively. These effects contribute to coughing, wheezing, shortness of breath, sore throat, and reduced exercise tolerance.

  For people with asthma or chronic obstructive pulmonary disease, exposure can provoke acute exacerbations that require medication, emergency care, or hospitalization. Air pollution is also associated with more frequent respiratory infections because impaired airway defenses make it harder to remove pathogens. Repeated inflammation may eventually contribute to airway remodeling and permanent loss of lung capacity.

  Long-term exposure has wider consequences. Children exposed during critical stages of lung growth may achieve a lower maximum lung function in adulthood. In adults, sustained particulate exposure is associated with faster lung-function decline and a higher likelihood of developing chronic bronchitis, COPD, or lung cancer. Cardiovascular effects can intensify these risks because the lungs and circulatory system respond to pollution together.

  Groups At Greater Risk

  Children breathe more air relative to their body size than adults and often spend time outdoors being physically active. Their lungs and immune systems are still developing, so traffic-related pollution and wildfire smoke may have lasting effects. Prenatal exposure can also influence fetal lung development and birth outcomes.

  Older adults and people living with asthma, COPD, bronchiectasis, pulmonary fibrosis, or cardiovascular disease may experience symptoms at lower pollution levels. Outdoor workers, people in dense urban neighborhoods, and communities located near highways or industrial facilities can face higher cumulative exposure. Social factors matter as well: housing quality, access to healthcare, and the ability to relocate or use air filtration can shape health outcomes.

  Pollutant or exposure	Common respiratory effects	People often most affected
  PM2.5 and wildfire smoke	Deep lung inflammation, asthma attacks, reduced lung function	Children, older adults, people with asthma or COPD
  PM10 and dust	Throat irritation, cough, worsened bronchitis	Outdoor workers, people with chronic airway disease
  Ozone	Wheezing, chest tightness, breathing difficulty during exertion	Children, athletes, people with asthma
  Nitrogen dioxide	Airway sensitivity, infections, impaired lung development	Children and urban residents
  Indoor smoke and mold	Persistent cough, allergic symptoms, asthma exacerbation	Infants, older adults, and people in poorly ventilated housing

  Measuring Risk In Daily Life

  Air-quality indexes convert complex monitoring data into public health guidance. Checking local pollution levels before outdoor exercise can help people choose safer times of day or move activity indoors. During smoke events, closing windows, using a properly maintained air cleaner, and avoiding activities that generate indoor particles can reduce exposure.

  Personal protection should be proportionate rather than alarmist. A well-fitted respirator may reduce inhalation of fine particles during severe smoke or dust episodes, but ordinary cloth face coverings offer limited protection against PM2.5. People with prescribed inhalers should follow their action plans and seek medical attention for severe breathlessness, bluish lips, confusion, or symptoms that do not improve with rescue medication.

  Clinicians can ask about home, workplace, commuting, and seasonal exposures as part of a respiratory assessment. This information may explain poorly controlled asthma or repeated exacerbations and can support targeted advice. For international respiratory congress participants, practical travel information is also relevant; delegates can review the K-ETA announcement while planning attendance and considering local air-quality conditions.

  Prevention Strategies That Reduce Exposure

  Reducing pollution at its source produces the greatest population benefit. Cleaner public transportation, vehicle-emission standards, renewable energy, safer industrial practices, and improved ventilation in schools and workplaces can lower community exposure. Indoor policies that eliminate tobacco smoke and support clean cooking technologies are equally important.

  Individuals can also reduce personal risk through small, consistent choices:

  • Check the local air-quality index before strenuous outdoor activity.
  • Keep windows closed during severe pollution or wildfire-smoke events.
  • Use high-efficiency filtration and replace filters according to manufacturer guidance.
  • Avoid burning candles, incense, wood, or trash indoors.
  • Follow an asthma or COPD action plan and keep essential medication available.

  Healthcare teams can support prevention by identifying high-risk patients, teaching inhaler technique, discussing occupational hazards, and providing written guidance for pollution episodes. Public health agencies can strengthen early-warning systems, communicate in accessible language, and ensure that alerts reach people without reliable internet access.

  Turning Environmental Evidence Into Care

  Respiratory health outcomes reflect the combined effects of pollution, infection, smoking, occupational hazards, housing, and access to treatment. Air pollution should therefore be treated as a modifiable clinical and public health exposure rather than an unavoidable background condition. Better monitoring and more detailed research can clarify which interventions protect lung function most effectively across different communities.

  The work presented through respiratory medicine networks and congresses can help connect laboratory findings with patient care, policy, and prevention. Clinicians, researchers, employers, educators, and residents all have a role in reducing harmful exposure and recognizing symptoms early.

  Use local air-quality information, strengthen indoor ventilation and filtration, and discuss pollution exposure during respiratory consultations. Acting on these steps can reduce exacerbations today while supporting healthier lungs for the years ahead.

  Richard Russell Nuffield Department of Clinical Medicine, University of Oxford (United Kingdom)
• Mona Bafadhel King’s College London (United Kingdom)
  David Jackson Guy’s and St Thomas’ Hospital, King’s College London (United Kingdom)
• James Chalmers University of Dundee (United Kingdom)
  David Price University of Aberdeen (United Kingdom)